FDA Import Refusal 112-6261666-2/1/1 — Caythorpe Limited

Caythorpe Limited — FEI 3009403475

The FDA refused shipment 112-6261666-2/1/1 from Caythorpe Limited (United Kingdom) on Mar 30, 2012. The refused product falls under Devices — CHROMOGENIC IN SITU HYBRIDISATION, NUCLEIC ACID AMPLIFICATION, HER2/NEU GENE, BREAST CANCER. Cited charges: 118,237

Refusal details

Date
Mar 30, 2012
Country
United Kingdom
Product Category
Devices
Product Code
82NYQ CHROMOGENIC IN SITU HYBRIDISATION, NUCLEIC ACID AMPLIFICATION, HER2/NEU GENE, BREAST CANCER
Charges
118,237

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.